| Literature DB >> 29914184 |
Yang Yang1, Liwen Luo2, Chao Song3,4,5, Hao Yin6,7, Jintao Yang8.
Abstract
Background: Particulate air pollution, especially PM2.5, is highly correlated with various adverse health impacts and, ultimately, economic losses for society, however, few studies have undertaken a spatiotemporal assessment of PM2.5-related economic losses from health impacts covering all of the main cities in China.Entities:
Keywords: China; PM2.5; economic loss; health impact; spatiotemporal assessment
Mesh:
Substances:
Year: 2018 PMID: 29914184 PMCID: PMC6024949 DOI: 10.3390/ijerph15061278
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Spatial distribution of PM2.5 in 2014 (a); 2015 (b); and 2016 (c).
Health impacts attributed to PM2.5 pollution in China during the period 2014–2016.
| Category | 2014 | 2015 | 2016 |
|---|---|---|---|
| All-cause mortality | 278,444 | 238,622 | 216,164 |
| Cardiovascular mortality | 71,058 | 60,991 | 55,321 |
| Respiratory mortality | 42,590 | 36,431 | 32,959 |
| Lung cancer mortality | 92,512 | 78,444 | 70,557 |
| Cardiovascular hospitalization | 1,001,233 | 851,497 | 767,387 |
| Chronic bronchitis | 185,798 | 159,366 | 144,459 |
| Acute bronchitis | 1,034,080 | 881,692 | 795,978 |
| Asthma attack | 19,197,994 | 15,935,983 | 14,130,036 |
| Affected population | 21,697,549 | 18,067,160 | 16,054,024 |
Figure 2PM2.5-related health impacts (all-cause mortality) in 20 major cities in China during the period 2014–2016.
Figure 3Spatial distribution of PM2.5-related health impacts (all-cause mortality) in 2014 (a); 2015 (b); and 2016 (c). Distribution of changes in PM2.5-related health impacts (all-cause mortality) for the periods 2014–2015 (d) and 2015–2016 (e).
Total economic losses from health impacts as a result of PM2.5 pollution during the period 2014–2016.
| Category | The Health Economic Loss (100 Million Dollar) | |||||
|---|---|---|---|---|---|---|
| 2014 AHC | 2014 VSL | 2015 AHC | 2015 VSL | 2016 AHC | 2016 VSL | |
| All-cause mortality | 256.32 | 1157.59 | 230.89 | 1061.69 | 214.16 | 1018.62 |
| Cardiovascular mortality | 65.46 | 295.48 | 59.03 | 271.44 | 54.84 | 260.75 |
| Respiratory mortality | 39.19 | 177 | 35.23 | 162.02 | 32.63 | 155.24 |
| Lung cancer mortality | 84.84 | 383.9 | 75.7 | 348.39 | 69.68 | 331.86 |
| Cardiovascular hospitalization | 12.2 | 12.2 | 10.95 | 10.95 | 10.28 | 10.28 |
| Chronic bronchitis | 42.48 | 42.48 | 39 | 39 | 37.44 | 37.44 |
| Acute bronchitis | 0.35 | 0.35 | 0.31 | 0.31 | 0.29 | 0.29 |
| Asthma attack | 6.57 | 6.57 | 5.8 | 5.8 | 5.4 | 5.4 |
| Total economic loss (TEL) | 317.93 | 1219.19 | 286.97 | 1117.76 | 267.38 | 1072.02 |
| TEL/GDP | 0.36% | 1.36% | 0.30% | 1.18% | 0.26% | 1.06% |
Figure 4PM2.5-related economic losses as a result of health impacts in 20 Chinese major cities in the lower bounds during the period 2014–2016.
Figure 5PM2.5-related economic losses as a result of health impacts in 20 Chinese major cities in the upper bounds during the period 2014–2016.
Figure 6Spatial distribution of PM2.5-related economic losses in the lower bounds in 2014 (a); 2015 (b); and 2016 (c). Distribution of changes in PM2.5-related economic losses in the lower bounds for the periods 2014–2015 (d) and 2015–2016 (e).
Figure 7Spatial distribution of PM2.5-related economic losses in the upper bounds in 2014 (a); 2015 (b); and 2016 (c). Distribution of changes in PM2.5-related economic losses in the upper bounds for the periods 2014–2015 (d) and 2015–2016 (e).
Figure 8Spatial distribution of uncertainty in relation to health-related economic losses using the value of a statistical life (VSL).